Skip to content

LLLT of Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency

New Combined Laser Therapy in Patients With Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03104985
Enrollment
68
Registered
2017-04-07
Start date
2013-05-31
Completion date
2015-12-31
Last updated
2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Venous Insufficiency, Trophic Ulcers

Keywords

Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency

Brief summary

The aim of this study was to evaluate comparatively the efficiency of traditional treatment methods in patients with chronic venous diseases of C6 class, and a new combined low level laser therapy (LLLT) by LASMIK device. The results of outpatient examination and treatment of patients with venous trophic ulcers, observed in the City Polyclinic of Tula Municipal Clinical Hospital №2 were analyzed.

Detailed description

During a longitudinal study, a group of patients was followed up in the period of complete or partial recovery. International classification of lower extremity chronic venous disorders СЕАР was used as a clinical classification of chronic venous insufficiency (CVI). Depending on the applied treatment method, patients were divided into 2 groups: 1. (n=34) Conventional treatment 2. (n=34) Conventional treatment + combined LLLT, including external exposure with 635nm wavelength + intravenous laser blood illumination (ILBI) with 365-405nm (UV-spectrum) and 520-525nm (green spectrum) wavelength alternately, according to the special scheme

Interventions

DEVICELASMIK

the physiotherapeutic device LASMIK (Registration Certificate in Russia № RZN 2015/2687 dated 25.05.2015).

OTHERConventional therapy

* An elastic compression of lower extremities, * Pharmacotherapy, * Topical treatment

Sponsors

Research Center Matrix
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* over 18 years of age, * CVI Stage 6 (S6) in compliance with СЕАР

Exclusion criteria

* hemorrhagic syndrome, * neoplastic syndrome, * hyperthermic syndrome (fever, patient body temperature over 38°C), * syndrome of systemic (cardiac, vascular, respiratory, renal and hepatic) and multiple organ failure (general severe illness), * cachexic syndrome (severe general exhaustion), * epileptic syndrome, * hysterical syndrome, * convulsive syndrome

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Trophic Ulcer Healing6 months follow upNumber of participants with ulcer epithelialization was counted in both groups. Trophic ulcer healing in 6 months occurred in larger number of participants of conventional therapy and combined LLLT group.

Countries

Russia

Participant flow

Participants by arm

ArmCount
Conventional Treatment
Conventional treatment only.
34
Conventional Therapy and Combined LLLT
Conventional therapy and combined LLLT (LASMIK device)
34
Total68

Baseline characteristics

CharacteristicConventional Therapy and Combined LLLTTotalConventional Treatment
Age, Continuous57.5 years57.2 years56.9 years
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Russia
34 Participants68 Participants34 Participants
Sex: Female, Male
Female
25 Participants50 Participants25 Participants
Sex: Female, Male
Male
9 Participants18 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Number of Participants With Trophic Ulcer Healing

Number of participants with ulcer epithelialization was counted in both groups. Trophic ulcer healing in 6 months occurred in larger number of participants of conventional therapy and combined LLLT group.

Time frame: 6 months follow up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Conventional TreatmentNumber of Participants With Trophic Ulcer Healing11 Participants
Conventional Therapy and Combined LLLTNumber of Participants With Trophic Ulcer Healing28 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026